-
€149,99 Incl. VAT
The following article was created to aid in the research for our list of the largest life science property investors in Europe. It includes in-depth acquisition profiles, as well as contact information and any available AUM figures.
The life science asset class includes laboratory and research buildings, often complemented by office space. This makes it particularly relevant for young and established companies in the pharmaceutical sector. In this article, we present three major life science investors in the German real estate market.
1. BEOS AG
BEOS AG is one of the leading developers and asset managers in Germany. It is a subsidiary of Swiss Life Asset Managers. The company is one of the leading investors in the German life science market. In November 2023, an 11,300 sqm property in Munich was acquired from HIH Invest. The medical technology company Livanova Deutschland uses 64 percent of the space for storage and production.
2. Diok Real Estate
Cologne-based Diok One AG has also been active in the German life science real estate market for some time. In June 2002, it acquired 89.9 % of the “Campteq Innovation Campus”. The property is rented to various tenants in the medical sector, such as Azenta Life Sciences. The total area of the property is 13,600 square meters.
3. La Francaise
The French real estate investor La Francaise Real Estate Investment Management is one of the leading real estate investors in Europe. It has recently made a number of acquisitions, particularly in the life sciences sector. The first property in this sector was also acquired in Germany in September 2022. A property in Nuremberg was purchased from Crescendo Real Estate Advisors. This will serve as Ziehm Imaging’s headquarters and development production site.
You also might the overview of the largest pharma companies in NRW from our partner portal hiddenchampion-ranking.
Image source: Julian Koblitz
